首页 > 最新文献

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)最新文献

英文 中文
[Characterization of peripheral blood cellular populations in relation to Ascaris Lumbricoides infection in rural areas of Bolívar]. [与玻利瓦尔农村地区蛔虫感染有关的外周血细胞群特征]。
Pub Date : 2024-02-01 DOI: 10.29262/ram.v71i1.1372
Ana Lozano, Victoria Marrugo, Juan Carlos Alvarado, Karen Hernandez, Kevin Llinás Caballero, Nathalie Acevedo, Josefina Zakzuk, Luis Caraballo

Objective: To compare the relative frequencies of immune cell populations in the peripheral blood according to A. lumbricoides infection status.

Methods: Peripheral blood samples were collected from participants infected (n = 35) and uninfected with A. lumbricoides (n=27) residing in different rural municipalities of Bolívar. Infection was diagnosed using two coprological examinations and the Kato-Katz technique. Immunophenotyping was performed using two panels of markers and staining in fresh blood. The flow cytometry reading was performed on a spectral cytometer (Northern Lights, Cytek, USA). The populations identified in the first panel (Figure 1) were T lymphocytes (CD45+ CD3+), CD4+ or CD8+, B lymphocytes (CD45+ SSClow CD3- CD19+), neutrophils (CD45+ SSChi CD3- CD16+), and eosinophils (CD45+ SSChi CD3- CD16low). Monocytes were identified in another panel (Figure 2): classical (CD14++ CD16 -), intermediate (CD14++ CD16+), and non-classical (CD14+ CD16++). Dendritic cells, including CD123 + + CD303 + (plasmacytoid), HLA-DR + + CD1c + (myeloid CD1c +), and CD14-CD141 + + (myeloid CD141 +), were also identified. The study received approval from the Ethics Committee of the University of Cartagena, and participants provided informed consent. Funding was provided by the Colombian Sistema General de Regalías under BPIN2020000100405 - BPIN2020000100364.

Results: No significant differences were observed in age [mean cases: 35.69 (SD: 17.7) vs. controls: 37.04 (SD: 15.6) years] or sex (cases: 62.9% vs. controls: 74.1%) (Table 1). All infections were mild, with a median of 96 eggs (IQR, 48-216). A marginally significant difference was observed only in the percentage of neutrophils (45.37% in cases vs. 54.79% in controls, p=0.041) (Figure 3). Although the frequency of eosinophils was higher in the cases (8.1% vs. 6%), this difference was not significant (p=0.138) (Figure 3). No significant differences were observed in the populations of monocytes or dendritic cells between cases and controls (Figure 4).

Conclusion: Mild A. lumbricoides infection appears to affect the number of neutrophils in peripheral blood. The low infection intensity in the studied samples may explain the lack of a significant impact on other cellular populations.

目的:比较外周血中免疫细胞群的相对频率:比较外周血中免疫细胞群的相对频率(根据蛔虫感染状况而定):方法:从居住在玻利瓦尔省不同农村地区的蛔虫感染者(35 人)和未感染者(27 人)中采集外周血样本。感染的诊断采用两次细胞学检查和卡托-卡茨技术。使用两组标记物和新鲜血液染色进行了免疫分型。流式细胞仪读数是在光谱细胞仪(Northern Lights,Cytek,美国)上进行的。第一组(图 1)鉴定的人群为 T 淋巴细胞(CD45+ CD3+)、CD4+ 或 CD8+、B 淋巴细胞(CD45+ SSClow CD3- CD19+)、中性粒细胞(CD45+ SSChi CD3- CD16+)和嗜酸性粒细胞(CD45+ SSChi CD3- CD16low)。单核细胞在另一个面板中被鉴定出来(图 2):经典单核细胞(CD14++ CD16-)、中间单核细胞(CD14++ CD16+)和非经典单核细胞(CD14+ CD16++)。树突状细胞也被鉴定出来,包括 CD123 + + CD303 +(浆细胞)、HLA-DR + + CD1c +(髓样 CD1c +)和 CD14-CD141 + +(髓样 CD141 +)。该研究获得了卡塔赫纳大学伦理委员会的批准,参与者提供了知情同意书。研究经费由哥伦比亚政府资助,项目编号为 BPIN2020000100405 - BPIN2020000100364:年龄[平均病例:35.69(标清:17.7)岁;对照组:37.04(标清:15.6)岁]和性别(病例:62.9%;对照组:74.1%)无明显差异(表 1)。所有感染均为轻度,中位数为 96 个鸡蛋(IQR,48-216)。仅在中性粒细胞的百分比上观察到微小的差异(病例为 45.37%,对照组为 54.79%,P=0.041)(图 3)。虽然病例中嗜酸性粒细胞的频率较高(8.1% 对 6%),但这一差异并不显著(P=0.138)(图 3)。病例和对照组的单核细胞或树突状细胞数量没有明显差异(图 4):结论:轻度蛔虫感染似乎会影响外周血中中性粒细胞的数量。研究样本中的感染强度较低,这可能是其他细胞群未受到显著影响的原因。
{"title":"[Characterization of peripheral blood cellular populations in relation to Ascaris Lumbricoides infection in rural areas of Bolívar].","authors":"Ana Lozano, Victoria Marrugo, Juan Carlos Alvarado, Karen Hernandez, Kevin Llinás Caballero, Nathalie Acevedo, Josefina Zakzuk, Luis Caraballo","doi":"10.29262/ram.v71i1.1372","DOIUrl":"https://doi.org/10.29262/ram.v71i1.1372","url":null,"abstract":"<p><strong>Objective: </strong>To compare the relative frequencies of immune cell populations in the peripheral blood according to <i>A. lumbricoides</i> infection status.</p><p><strong>Methods: </strong>Peripheral blood samples were collected from participants infected (n = 35) and uninfected with <i>A. lumbricoides</i> (n=27) residing in different rural municipalities of Bolívar. Infection was diagnosed using two coprological examinations and the Kato-Katz technique. Immunophenotyping was performed using two panels of markers and staining in fresh blood. The flow cytometry reading was performed on a spectral cytometer (Northern Lights, Cytek, USA). The populations identified in the first panel (Figure 1) were T lymphocytes (CD45+ CD3+), CD4+ or CD8+, B lymphocytes (CD45+ SSClow CD3- CD19+), neutrophils (CD45+ SSChi CD3- CD16+), and eosinophils (CD45+ SSChi CD3- CD16low). Monocytes were identified in another panel (Figure 2): classical (CD14++ CD16 -), intermediate (CD14++ CD16+), and non-classical (CD14+ CD16++). Dendritic cells, including CD123 + + CD303 + (plasmacytoid), HLA-DR + + CD1c + (myeloid CD1c +), and CD14-CD141 + + (myeloid CD141 +), were also identified. The study received approval from the Ethics Committee of the University of Cartagena, and participants provided informed consent. Funding was provided by the Colombian Sistema General de Regalías under BPIN2020000100405 - BPIN2020000100364.</p><p><strong>Results: </strong>No significant differences were observed in age [mean cases: 35.69 (SD: 17.7) vs. controls: 37.04 (SD: 15.6) years] or sex (cases: 62.9% vs. controls: 74.1%) (Table 1). All infections were mild, with a median of 96 eggs (IQR, 48-216). A marginally significant difference was observed only in the percentage of neutrophils (45.37% in cases vs. 54.79% in controls, p=0.041) (Figure 3). Although the frequency of eosinophils was higher in the cases (8.1% vs. 6%), this difference was not significant (p=0.138) (Figure 3). No significant differences were observed in the populations of monocytes or dendritic cells between cases and controls (Figure 4).</p><p><strong>Conclusion: </strong>Mild <i>A. lumbricoides</i> infection appears to affect the number of neutrophils in peripheral blood. The low infection intensity in the studied samples may explain the lack of a significant impact on other cellular populations.</p>","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"71 1","pages":"69"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140874103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Post-COVID-19 condition in children and adolescents from a cohort: prevalence and risk factors]. [来自队列的儿童和青少年中的后 COVID-19 症状:发病率和风险因素]。
Pub Date : 2024-02-01 DOI: 10.29262/ram.v71i1.1285
Sergio Iván Assia-Robles, María Del Rocío Hernández-Morales, Eleazar Mancilla-Hernández, Diana Paola López-Méndez, Samara Nazarala-Sanchez, Sandra Aidée González-Hidalgo

Objective: To determine the prevalence and risk factors of the post-COVID-19 condition of children and adolescents from a cohort.

Methods: Observational and analytical cohort study. Statistical analysis: percentages, frequencies; averages; Odds ratio, χ2 test, and multiple binary logistic regression. Statistical Package, for the Social Sciences 23.

Results: Prevalence of the post-COVID-19 condition was: 14.8% of 175 patients who fulfilled the inclusion criteria, 26 developed post-COVID-19 condition, mean age 5.9 years (SD: 5.05), sex: 27% men, 73% women, frequent symptoms: fatigue, runny nose, muscle pain, dyspnea. Symptoms associated with post-COVID-19 condition: muscle pain (OR: 27; p = 0.000; IC95%5.2-139), dysgeusia (OR: 19; p = 0.012; IC95%: 1.9-19), and fatigue (OR: 5; p = 0.001; IC95%: 1.9-13.5). Associated risk factors: female (OR: 3.58; p = 0.023; CI95%: 1.19-10.71), comorbidities (OR: 24.5; p = 0.000; CI95%: 7.52-79), allergic rhinitis (OR: 8.7; p = 0.000; CI95%: 2.66-28.87), atopic dermatitis (OR: 9. 58; p = 0.016 CI95%: 1.51-60.5).

Conclusions: Although the majority of children infected with SARS-CoV-2 recover completely, some of them will develop a post-COVID-19 condition, knowing the most frequent symptoms and associated factors, will allow a better evaluation, for its opportune detection and effective treatment.

目的从队列中确定儿童和青少年 COVID-19 后状况的流行率和风险因素:观察和分析队列研究。统计分析:百分比、频率、平均值、比率、χ2 检验和多元二元逻辑回归。采用社会科学统计软件包 23.结果:符合纳入标准的 175 名患者中,COVID-19 后病症的患病率为 14.8%,26 人出现 COVID-19 后病症,平均年龄为 5.9 岁(标清:5.05),性别:27% 为男性,73% 为女性,常见症状:疲劳、流鼻涕、肌肉疼痛、呼吸困难。与 COVID-19 后症状相关的症状:肌肉疼痛(OR:27;P = 0.000;IC95%5.2-139)、呼吸困难(OR:19;P = 0.012;IC95%:1.9-19)和疲劳(OR:5;P = 0.001;IC95%:1.9-13.5)。相关风险因素:女性(OR:3.58;p = 0.023;CI95%:1.19-10.71)、合并症(OR:24.5;p = 0.000;CI95%:7.52-79)、过敏性鼻炎(OR:8.7;p = 0.000;CI95%:2.66-28.87)、特应性皮炎(OR:9.58;p = 0.016 CI95%:1.51-60.5):虽然大多数感染 SARS-CoV-2 的儿童都能完全康复,但其中一些儿童会出现后 COVID-19 症状,了解最常见的症状和相关因素将有助于更好地进行评估,以便及时发现和有效治疗。
{"title":"[Post-COVID-19 condition in children and adolescents from a cohort: prevalence and risk factors].","authors":"Sergio Iván Assia-Robles, María Del Rocío Hernández-Morales, Eleazar Mancilla-Hernández, Diana Paola López-Méndez, Samara Nazarala-Sanchez, Sandra Aidée González-Hidalgo","doi":"10.29262/ram.v71i1.1285","DOIUrl":"10.29262/ram.v71i1.1285","url":null,"abstract":"<p><strong>Objective: </strong>To determine the prevalence and risk factors of the post-COVID-19 condition of children and adolescents from a cohort.</p><p><strong>Methods: </strong>Observational and analytical cohort study. Statistical analysis: percentages, frequencies; averages; Odds ratio, χ<sup>2</sup> test, and multiple binary logistic regression. Statistical Package, for the Social Sciences 23.</p><p><strong>Results: </strong>Prevalence of the post-COVID-19 condition was: 14.8% of 175 patients who fulfilled the inclusion criteria, 26 developed post-COVID-19 condition, mean age 5.9 years (SD: 5.05), sex: 27% men, 73% women, frequent symptoms: fatigue, runny nose, muscle pain, dyspnea. Symptoms associated with post-COVID-19 condition: muscle pain (OR: 27; p = 0.000; IC95%5.2-139), dysgeusia (OR: 19; p = 0.012; IC95%: 1.9-19), and fatigue (OR: 5; p = 0.001; IC95%: 1.9-13.5). Associated risk factors: female (OR: 3.58; p = 0.023; CI95%: 1.19-10.71), comorbidities (OR: 24.5; p = 0.000; CI95%: 7.52-79), allergic rhinitis (OR: 8.7; p = 0.000; CI95%: 2.66-28.87), atopic dermatitis (OR: 9. 58; p = 0.016 CI95%: 1.51-60.5).</p><p><strong>Conclusions: </strong>Although the majority of children infected with SARS-CoV-2 recover completely, some of them will develop a post-COVID-19 condition, knowing the most frequent symptoms and associated factors, will allow a better evaluation, for its opportune detection and effective treatment.</p>","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"71 1","pages":"23-28"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140872994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Characterization of asthma phenotypes in children of the tropics]. [热带地区儿童哮喘表型的特征]。
Pub Date : 2024-02-01 DOI: 10.29262/ram.v71i1.1362
María Camila Guzmán, María de Vivero, Isabel Gil, Victoria Marrugo, Dilia Mercado, Josefina Zakzuk, Leonardo Puerta, Nathalie Acevedo, Luis Caraballo

Objective: Determine the main asthma phenotypes in a population of asthmatic children in Cartagena, Colombia.

Methods: 107 children (7 to 17 years old) with a previous diagnosis of asthma were recruited. Biomarkers of T2 inflammation were evaluated by measuring FeNO, eosinophil count in peripheral blood by hemocytometry, and determination of specific IgE to mite allergens by ELISA. The study was approved by the ethics committee of the University of Cartagena (SGR, Grant BPIN2020000100405).

Results: The average age of patients was 10,9 years. 19,6% of the children did not show elevation of any of the T2 inflammation biomarkers evaluated (FeNO<20ppb, eos<300/ul, negative specific IgE), so they were considered patients with non-allergic asthma (non-T2). 71,9% of all patients were sensitized to at least one allergen, this phenotype was considered allergic asthma. 30,8% of the patients presented the three elevated biomarkers (FeNO>20ppb + eos >300/ul + positive specific IgE), this phenotype was classified as high T2 allergic asthma. A moderate correlation (Spearman rho=0,44, p<0,0001) was found between FeNO values and eosinophil counts.

Conclusion: In this study, the following phenotypes were found: allergic asthma, high T2 asthma, and non-allergic asthma. Most patients presented a type 2 inflammatory phenotype with allergic sensitization. In addition to the measurement of specific IgE, the use of FeNO and eosinophil count in peripheral blood help to accurately determine those patients with high T2 asthma phenotypes.

目的:确定哥伦比亚卡塔赫纳哮喘儿童的主要哮喘表型:方法:招募 107 名曾被诊断为哮喘的儿童(7 至 17 岁)。通过测量 FeNO、血球计数法检测外周血中的嗜酸性粒细胞数量以及酶联免疫吸附法测定螨虫过敏原的特异性 IgE,评估 T2 炎症的生物标志物。该研究获得了卡塔赫纳大学伦理委员会(SGR,Grant BPIN2020000100405)的批准:患者平均年龄为 10.9 岁。19.6%的儿童没有出现任何T2炎症生物标志物升高(FeNO20ppb + eos >300/ul + 特异性 IgE 阳性),这种表型被归类为高T2过敏性哮喘。中度相关性(Spearman rho=0,44,pConclusion):本研究发现了以下几种表型:过敏性哮喘、高 T2 哮喘和非过敏性哮喘。大多数患者表现为具有过敏致敏性的 2 型炎症表型。除了测量特异性 IgE 外,使用 FeNO 和外周血中的嗜酸性粒细胞计数有助于准确判断高 T2 哮喘表型患者。
{"title":"[Characterization of asthma phenotypes in children of the tropics].","authors":"María Camila Guzmán, María de Vivero, Isabel Gil, Victoria Marrugo, Dilia Mercado, Josefina Zakzuk, Leonardo Puerta, Nathalie Acevedo, Luis Caraballo","doi":"10.29262/ram.v71i1.1362","DOIUrl":"https://doi.org/10.29262/ram.v71i1.1362","url":null,"abstract":"<p><strong>Objective: </strong>Determine the main asthma phenotypes in a population of asthmatic children in Cartagena, Colombia.</p><p><strong>Methods: </strong>107 children (7 to 17 years old) with a previous diagnosis of asthma were recruited. Biomarkers of T2 inflammation were evaluated by measuring FeNO, eosinophil count in peripheral blood by hemocytometry, and determination of specific IgE to mite allergens by ELISA. The study was approved by the ethics committee of the University of Cartagena (SGR, Grant BPIN2020000100405).</p><p><strong>Results: </strong>The average age of patients was 10,9 years. 19,6% of the children did not show elevation of any of the T2 inflammation biomarkers evaluated (FeNO<20ppb, eos<300/ul, negative specific IgE), so they were considered patients with non-allergic asthma (non-T2). 71,9% of all patients were sensitized to at least one allergen, this phenotype was considered allergic asthma. 30,8% of the patients presented the three elevated biomarkers (FeNO>20ppb + eos >300/ul + positive specific IgE), this phenotype was classified as high T2 allergic asthma. A moderate correlation (Spearman rho=0,44, p<0,0001) was found between FeNO values and eosinophil counts.</p><p><strong>Conclusion: </strong>In this study, the following phenotypes were found: allergic asthma, high T2 asthma, and non-allergic asthma. Most patients presented a type 2 inflammatory phenotype with allergic sensitization. In addition to the measurement of specific IgE, the use of FeNO and eosinophil count in peripheral blood help to accurately determine those patients with high T2 asthma phenotypes.</p>","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"71 1","pages":"74"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140871888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[IgE reactivity of sera from patients with autoimmune diseases against a multi-epitope protein constructed from T epitopes of Ascaris lumbricoides allergens]. [自身免疫性疾病患者血清对由蛔虫过敏原 T 表位构建的多表位蛋白的 IgE 反应性]。
Pub Date : 2024-02-01 DOI: 10.29262/ram.v71i1.1366
Luis Fang, Dalgys Martínez, Catherine Meza-Torres, Ana Moreno-Woo, Nicole Pereira-Sanandres, Alex Domínguez-Vargas, Gloria Garavito, Eduardo Egea

Objective: To evaluate the IgE reactivity of sera in patients suffering from type 1 diabetes (T1D), lupus nephritis (LN) and juvenile idiopathic arthritis (JIA) against a molecule constructed from T epitopes of A. lumbricoides allergens.

Methods: We designed and expressed a synthetic multi-epítope protein named MP1 from A. lumbricoides and house dust mites allergens. By indirect ELISA, we evaluated IgE-reactivity to MP1 and to the whole-body extract of Ascaris lumbricoides in 45 sera from Colombian Caribbean patients with lupus nephritis (LN; n=25), type 1 diabetes (T1D; n=10) and Juvenil idiopathic arthritis (JIA; n=10). Individuals with poly autoimmunity were excluded. All patients were referred to the study by their specialist doctor.

Results: IgE to whole-body extract of A. lumbricoides showed the following median concentrations.

484.2 ng/ml (IQR: 203.4) in JIA patients, 325.6 ng/ml (IQR: 179.3) in individuals with LN, and 424.7 ng/ml (IQR: 80.1) in the T1D group. On the other hand, IgE-reactivity to MP1 was 126.4 ng/ml (IQR: 90.9) in JIA patients, 130.7 ng/ml (IQR: 94.8) in an individual with LN, and 148.8 ng/ml (IQR: 102.1) in the T1D group. Although no statistical differences were observed between patient groups, the IgE to MP1 in all patients (n: 45) (IgE median: 134.2 ng/ml; IQR: 100) were significantly less compared to Ascaris extract (IgE median: 380.7 ng/ml; IQR: 175.8); (W: 0.732; p-value: 1.034x10-7).

Conclusions: These preliminary results suggest that MP1 showed antigenic properties with low IgE- reactivity, compared to Ascaris lumbricoides extracted in individuals with autoimmune diseases. Further studies are needed to understand better the immune response induced by this molecule.

目的评估 1 型糖尿病 (T1D)、狼疮性肾炎 (LN) 和幼年特发性关节炎 (JIA) 患者血清中 IgE 对由 A. lumbricoides 过敏原 T 表位构建的分子的反应性:方法:我们设计并表达了一种人工合成的多表位蛋白,命名为MP1。通过间接 ELISA 法,我们评估了 45 名患有狼疮性肾炎(LN;n=25)、1 型糖尿病(T1D;n=10)和幼年特发性关节炎(JIA;n=10)的哥伦比亚加勒比海患者血清中对 MP1 和蛔虫全身提取物的 IgE 反应性。患有多种自身免疫疾病的患者不包括在内。所有患者均由其专科医生转介至本研究:JIA患者的IgE中位数为484.2纳克/毫升(IQR:203.4),LN患者为325.6纳克/毫升(IQR:179.3),T1D组为424.7纳克/毫升(IQR:80.1)。另一方面,JIA 患者对 MP1 的 IgE 反应性为 126.4 纳克/毫升(IQR:90.9),LN 患者为 130.7 纳克/毫升(IQR:94.8),T1D 组为 148.8 纳克/毫升(IQR:102.1)。虽然患者组之间没有统计学差异,但与蛔虫提取物(IgE 中位数:380.7 ng/ml;IQR:175.8)相比,所有患者(n:45)对 MP1 的 IgE(IgE 中位数:134.2 ng/ml;IQR:100)显著降低;(W:0.732;P 值:1.034x10-7):这些初步结果表明,与蛔虫提取物相比,MP1 在自身免疫性疾病患者中显示出低 IgE 反应性的抗原特性。要更好地了解该分子诱导的免疫反应,还需要进一步研究。
{"title":"[IgE reactivity of sera from patients with autoimmune diseases against a multi-epitope protein constructed from T epitopes of Ascaris lumbricoides allergens].","authors":"Luis Fang, Dalgys Martínez, Catherine Meza-Torres, Ana Moreno-Woo, Nicole Pereira-Sanandres, Alex Domínguez-Vargas, Gloria Garavito, Eduardo Egea","doi":"10.29262/ram.v71i1.1366","DOIUrl":"https://doi.org/10.29262/ram.v71i1.1366","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the IgE reactivity of sera in patients suffering from type 1 diabetes (T1D), lupus nephritis (LN) and juvenile idiopathic arthritis (JIA) against a molecule constructed from T epitopes of <i>A. lumbricoides</i> allergens.</p><p><strong>Methods: </strong>We designed and expressed a synthetic multi-epítope protein named MP1 from A. lumbricoides and house dust mites allergens. By indirect ELISA, we evaluated IgE-reactivity to MP1 and to the whole-body extract of <i>Ascaris lumbricoides</i> in 45 sera from Colombian Caribbean patients with lupus nephritis (LN; n=25), type 1 diabetes (T1D; n=10) and Juvenil idiopathic arthritis (JIA; n=10). Individuals with poly autoimmunity were excluded. All patients were referred to the study by their specialist doctor.</p><p><strong>Results: </strong>IgE to whole-body extract of <i>A. lumbricoides</i> showed the following median concentrations.</p><p><p>484.2 ng/ml (IQR: 203.4) in JIA patients, 325.6 ng/ml (IQR: 179.3) in individuals with LN, and 424.7 ng/ml (IQR: 80.1) in the T1D group. On the other hand, IgE-reactivity to MP1 <i>was 126.4 ng/ml (IQR: 90.9) in JIA patients, 130.7 ng/ml (IQR: 94.8) in an</i> individual with LN, and 148.8 ng/ml (IQR: 102.1) in the T1D group. Although no statistical differences were observed between patient groups, the IgE to MP1 in all patients (n: 45) (IgE median: 134.2 ng/ml; IQR: 100) were significantly less compared to Ascaris extract (IgE median: 380.7 ng/ml; IQR: 175.8); (<i>W:</i> 0.732; <i>p-value:</i> 1.034x10<sup>-7</sup>).</p><p><strong>Conclusions: </strong>These preliminary results suggest that MP1 showed antigenic properties with low IgE- reactivity, compared to <i>Ascaris lumbricoides</i> extracted in individuals with autoimmune diseases. Further studies are needed to understand better the immune response induced by this molecule.</p>","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"71 1","pages":"53"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140867527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Topical Use of Cannabis in Inflammatory Diseases in patients of the IPS Salud Social in Barranquilla, Colombia]. [哥伦比亚巴兰基亚 IPS Salud Social 病人局部使用大麻治疗炎症性疾病]。
Pub Date : 2024-02-01 DOI: 10.29262/ram.v71i1.1351
Juan Calderón, Carlos Parga-Lozano, Nohemí Santodomingo, Paola Gutiérrez, Fanny Lambraño

Objective: To relate the topical use of cannabis as an analgesic therapeutic alternative in patients with some inflammatory diseases in Salud Social I.P.S during May to July 2023.

Methods: An analytical, retrospective study was carried out. The population from which the sample was obtained corresponds to patients diagnosed with Arthrosis, Unspecified, Non-Toxic Multinodular Goiter, Epilepsy, Unspecified Type Venous Insufficiency (Chronic) (Peripheral), Unspecified Lumbago, Secondary Gonarthrosis, Rotator Cuff Syndrome, Carpal Tunnel Syndrome, in Salud Social I.P.S of Barranquilla, Atlántico. A sample of 23 patients diagnosed with these pathologies was obtained by non-probabilistic convenience sampling.

Results: All patients showed pain relief after two months of follow-up, two experienced adverse effects. Some studies suggest that cannabinoids present in cannabis, such as CBD and THC, may have analgesic and anti-inflammatory properties that could alleviate pain and inflammation associated with these conditions. This is consistent with the present study.

Conclusion: Topical cannabis is presented as a therapeutic alternative in inflammatory diseases, however, it is important to highlight that research on the use of cannabis in these diseases is limited and more studies are needed to fully understand its effects and potential benefits.

目的分析 2023 年 5 月至 7 月期间社会健康研究所(Salud Social I.P.S)一些炎症性疾病患者局部使用大麻作为镇痛治疗替代品的情况:进行了一项分析性、回顾性研究。获得样本的人群是巴兰基亚市社会医疗保险局(Salud Social I.P.S)中被诊断患有关节炎、不明原因、非毒性多结节性甲状腺肿、癫痫、不明原因的(慢性)静脉功能不全(外周)、不明原因的腰痛、继发性椎关节炎、肩袖综合征、腕管综合征的患者。通过非概率方便抽样法获得了 23 名被诊断患有上述病症的患者样本:结果:所有患者在两个月的随访后疼痛均有所缓解,其中两人出现了不良反应。一些研究表明,大麻中的大麻素(如 CBD 和 THC)可能具有镇痛和抗炎特性,可以减轻与这些病症相关的疼痛和炎症。这与本研究的结论一致:外用大麻被认为是治疗炎症性疾病的一种替代疗法,但必须强调的是,有关大麻用于这些疾病的研究还很有限,需要进行更多的研究,以充分了解其效果和潜在益处。
{"title":"[Topical Use of Cannabis in Inflammatory Diseases in patients of the IPS Salud Social in Barranquilla, Colombia].","authors":"Juan Calderón, Carlos Parga-Lozano, Nohemí Santodomingo, Paola Gutiérrez, Fanny Lambraño","doi":"10.29262/ram.v71i1.1351","DOIUrl":"https://doi.org/10.29262/ram.v71i1.1351","url":null,"abstract":"<p><strong>Objective: </strong>To relate the topical use of cannabis as an analgesic therapeutic alternative in patients with some inflammatory diseases in Salud Social I.P.S during May to July 2023.</p><p><strong>Methods: </strong>An analytical, retrospective study was carried out. The population from which the sample was obtained corresponds to patients diagnosed with Arthrosis, Unspecified, Non-Toxic Multinodular Goiter, Epilepsy, Unspecified Type Venous Insufficiency (Chronic) (Peripheral), Unspecified Lumbago, Secondary Gonarthrosis, Rotator Cuff Syndrome, Carpal Tunnel Syndrome, in Salud Social I.P.S of Barranquilla, Atlántico. A sample of 23 patients diagnosed with these pathologies was obtained by non-probabilistic convenience sampling.</p><p><strong>Results: </strong>All patients showed pain relief after two months of follow-up, two experienced adverse effects. Some studies suggest that cannabinoids present in cannabis, such as CBD and THC, may have analgesic and anti-inflammatory properties that could alleviate pain and inflammation associated with these conditions. This is consistent with the present study.</p><p><strong>Conclusion: </strong>Topical cannabis is presented as a therapeutic alternative in inflammatory diseases, however, it is important to highlight that research on the use of cannabis in these diseases is limited and more studies are needed to fully understand its effects and potential benefits.</p>","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"71 1","pages":"76"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140874399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Anaphylaxis due to legumes: case report]. [豆类引起的过敏性休克:病例报告]。
Pub Date : 2024-02-01 DOI: 10.29262/ram.v71i1.1358
Leidy Johana Alzate-Pérez, Natalia Aguirre-Morales, Libia Susana Diez-Zuluaga

Background: Legumes belonging to the family Fabaceae of the order Fabales are a widely consumed source of protein. IgE-mediated hypersensitivity reactions to legumes have been described, the most studied allergens being peanuts and soybeans. In the Mediterranean region and India, lentils, chickpeas and peas have been considered important allergens and legumes have been reported to represent the fifth most common cause of food allergy in children under 5 years of age in Spain. In Latin America, there are few reports of allergy to legumes other than peanuts, and these are especially in the paediatric population.

Objective: To describe a case of IgE-mediated legume allergy in an adult female patient.

Case report: We describe the case of a 65-year-old female patient who reports a 20-year history of generalized urticaria, accompanied by angioedema and dyspnea occurring immediately after consumption of lentils, beans, chickpeas, soya beans and cold meats, requiring admission to the emergency department for this cause. Tolerates peanuts. She does not report anaphylaxis in any context other than those described. He has presented generalized pruritus with exposure to fumes from cooking beans. Pathological history: Hypertension, type II diabetes mellitus, hypothyroidism. Allergic: Anaphylaxis due to penicillin at the age of 30. Other history: extensive local reaction to hymenoptera sting. Prick test trophoallergens: soya 3 mm. Prick to prick protein based on commercial soybean 7mm, chickpea 5mm, lentil 6mm and bean 7mm. He was negative for wheat and peanut (Image 1) (Attached in separate file). It has a normal tryptase report. Indication was given for adequate adrenaline and strict avoidance of legumes, except peanuts.

Conclusions: Legume allergy is little known in our environment and mainly affects children. Clinical manifestations include mild reactions and anaphylaxis. A high degree of cross-reactivity among legumes has been reported. Lentils have cross-reactivity with chickpeas and beans. Peanut allergy may also be associated with allergy to lentils, chickpeas, and peas, but is less frequently reported.

背景:豆科植物是人们广泛食用的蛋白质来源。IgE 介导的豆类超敏反应已有描述,研究最多的过敏原是花生和大豆。在地中海地区和印度,扁豆、鹰嘴豆和豌豆被认为是重要的过敏原,据报道,在西班牙,豆类是导致 5 岁以下儿童食物过敏的第五大原因。在拉丁美洲,除花生外,很少有豆类过敏的报道,尤其是在儿科人群中:病例报告:我们描述了一例 65 岁女性患者的病例,她在 20 年前就出现了全身性荨麻疹,并伴有血管性水肿和呼吸困难,在食用小扁豆、豆类、鹰嘴豆、大豆和冷肉后立即发病,因此需要到急诊科就诊。可以吃花生。除上述情况外,她未报告过任何其他情况下的过敏性休克。他曾因接触烹饪豆类的油烟而全身瘙痒。病史:高血压、II 型糖尿病、甲状腺功能减退。过敏:30 岁时因青霉素引起过敏性休克。其他病史:对膜翅目昆虫蛰伤有广泛的局部反应。滴刺试验滋养过敏原:大豆 3 毫米。对商品大豆 7 毫米、鹰嘴豆 5 毫米、扁豆 6 毫米和蚕豆 7 毫米的挑刺蛋白质。他对小麦和花生过敏(图片 1)(另附)。胰蛋白酶报告正常。医生建议给予足够的肾上腺素,并严格避免食用豆科植物(花生除外):豆类过敏在我们的环境中鲜为人知,主要影响儿童。临床表现包括轻度反应和过敏性休克。据报道,豆科植物之间存在高度的交叉反应。扁豆与鹰嘴豆和豆类有交叉反应。花生过敏也可能与扁豆、鹰嘴豆和豌豆过敏有关,但较少报道。
{"title":"[Anaphylaxis due to legumes: case report].","authors":"Leidy Johana Alzate-Pérez, Natalia Aguirre-Morales, Libia Susana Diez-Zuluaga","doi":"10.29262/ram.v71i1.1358","DOIUrl":"10.29262/ram.v71i1.1358","url":null,"abstract":"<p><strong>Background: </strong>Legumes belonging to the family <i>Fabaceae</i> of the order <i>Fabales</i> are a widely consumed source of protein. IgE-mediated hypersensitivity reactions to legumes have been described, the most studied allergens being peanuts and soybeans. In the Mediterranean region and India, lentils, chickpeas and peas have been considered important allergens and legumes have been reported to represent the fifth most common cause of food allergy in children under 5 years of age in Spain. In Latin America, there are few reports of allergy to legumes other than peanuts, and these are especially in the paediatric population.</p><p><strong>Objective: </strong>To describe a case of IgE-mediated legume allergy in an adult female patient.</p><p><strong>Case report: </strong>We describe the case of a 65-year-old female patient who reports a 20-year history of generalized urticaria, accompanied by angioedema and dyspnea occurring immediately after consumption of lentils, beans, chickpeas, soya beans and cold meats, requiring admission to the emergency department for this cause. Tolerates peanuts. She does not report anaphylaxis in any context other than those described. He has presented generalized pruritus with exposure to fumes from cooking beans. <i>Pathological history</i>: Hypertension, type II diabetes mellitus, hypothyroidism. <i>Allergic</i>: Anaphylaxis due to penicillin at the age of 30. <i>Other history</i>: extensive local reaction to hymenoptera sting. Prick test trophoallergens: soya 3 mm. Prick to prick protein based on commercial soybean 7mm, chickpea 5mm, lentil 6mm and bean 7mm. He was negative for wheat and peanut (Image 1) (Attached in separate file). It has a normal tryptase report. Indication was given for adequate adrenaline and strict avoidance of legumes, except peanuts.</p><p><strong>Conclusions: </strong>Legume allergy is little known in our environment and mainly affects children. Clinical manifestations include mild reactions and anaphylaxis. A high degree of cross-reactivity among legumes has been reported. Lentils have cross-reactivity with chickpeas and beans. Peanut allergy may also be associated with allergy to lentils, chickpeas, and peas, but is less frequently reported.</p>","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"71 1","pages":"63"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140861525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Case series of hereditary angioedema patients and use of tranexamic acid treatments in prophylaxis and acute crisis, experience in Perú]. [遗传性血管性水肿患者病例系列及使用氨甲环酸预防和治疗急性水肿,秘鲁的经验]。
Pub Date : 2024-02-01 DOI: 10.29262/ram.v71i1.1319
Oscar Calderón, Danny Muñoz, Margarita Olivares

Background: Hereditary Angioedema (HAE) is a rare disease characterized by episodes of swelling, HAE crisis could cause death by suffocation, and also affect the quality of life in these patients. There exists an important disparity of HAE specific treatments between countries, inclusive in the same region, currently in Perú we use moderate and high doses of Tranexamic Acid (TA) in prophylaxis therapy and in acute HAE crisis respectively.

Objective: To report our experience with TA in three types of HAE patients and be a guide to other countries with this therapy, where HAE specific treatments are not registered.

Case report: Patient 1: Woman. 49 years old. HAE-1. Symptoms began at the age of 12. Her final diagnosis was at age 45. Usually presents an acute crisis every two months approximately, she receives 2 g IV of TA when lips, tongue, facial episodes is beginning, eventually she needed other 1 - 2 g IV (after 4 hours). She receives Long-Term Prophylaxis (LTP) with TA (500 - 750 mg)/12 h. Patient 2: Woman 47 years old, HAE nC1INH-FXII. Symptoms began at the age of 19, during her first pregnancy, her definitive diagnosis was at the age of 41 years. She maintains a prophylaxis treatment of TA (750 mg-1,5 g)/daily; upper airway attacks are treated immediately with TA doses (1 - 2 g) when the crisis is beginning. Patient 3: Woman 43 years old, HAE-nC1INH-U. Genetic study did not recognize SERPING1, PLG1, ANGPT1, KNG1, FXII, mutations. Symptoms began at age 4, and her final diagnosis was at age 36. When the attack is beginning, she immediately receives TA (500 - 750 mg) orally / 12 hours during 2 to 3 days with acceptable tolerance and control of the HAE episodes. While the patients receive TA prophylaxis treatment doses (500 - 750 mg) every 8 or 12 hours respectively, the HAE episodes are less symptomatic and resolve in a few days.

Conclusions: We found this systematic review, used TA orally, on-demand and prophylaxis therapy, maximum cumulative dose 3 g/24 h1. In our HAE patients, we used TA up to 4 g (2 g - 2 g) intravenous for control of acute crisis in a interval of 4 hours, when decreases the reaction, the orally maintenance dose should be prescribed, 1 g/8 h with a progressive decrease of the dose in the next days. Tranexamic Acid treatment was useful in our different types of HAE patients. Most of our patients use high doses of TA to slow down and stop slowly the HAE crisis. TA is probably an option in countries where specific treatments are not registered, it could be administered orally and/or intravenous. High doses of TA were well tolerated and with acceptable response in HAE attacks.

背景:遗传性血管性水肿(HAE)是一种罕见疾病,其特点是发作性浮肿,HAE危象可导致患者窒息死亡,并影响患者的生活质量。目前,在秘鲁,我们使用中等剂量和高剂量的氨甲环酸(TA)分别用于预防治疗和急性血管性水肿危象:报告我们使用氨甲环酸治疗三种类型 HAE 患者的经验,并为其他未注册 HAE 特定治疗方法的国家使用该疗法提供指导:患者 1:女性。49岁。HAE-1。12 岁开始出现症状,45 岁最终确诊。通常大约每两个月就会出现一次急性危象,当嘴唇、舌头和面部开始发作时,她会接受 2 克的 TA 静脉注射,最后她还需要 1 - 2 克的其他静脉注射(4 小时后)。患者 2:女性,47 岁,HAE nC1INH-FXII。19岁第一次怀孕时开始出现症状,41岁时确诊。她每天服用 TA(750 毫克-1.5 克)进行预防性治疗;上呼吸道疾病发作时,立即服用 TA(1 - 2 克)进行治疗。患者 3:女性,43 岁,HAE-nC1INH-U。基因研究未发现 SERPING1、PLG1、ANGPT1、KNG1、FXII 突变。4 岁开始出现症状,36 岁时最终确诊。发作开始时,她立即口服 TA(500 - 750 毫克),每 12 小时一次,持续 2 至 3 天,耐受性良好,HAE 发作得到控制。当患者分别每 8 或 12 小时接受一次 TA 预防性治疗剂量(500 - 750 毫克)时,HAE 发作的症状会减轻,并在几天内缓解:我们发现这篇系统性综述使用了口服 TA,按需和预防治疗,最大累积剂量为 3 g/24 h1。在我们的HAE患者中,我们静脉注射氨甲环酸最多达4克(2克-2克)以控制急性危象,间隔时间为4小时,当反应减轻时,应口服维持剂量,1克/8小时,并在接下来的几天中逐渐减少剂量。氨甲环酸治疗对不同类型的HAE患者都很有用。我们的大多数患者都使用大剂量氨甲环酸来减缓和停止HAE危机。在未注册特定治疗方法的国家,氨甲环酸可能是一种选择,它可以口服和/或静脉注射。大剂量TA的耐受性良好,对HAE发作的反应也可接受。
{"title":"[Case series of hereditary angioedema patients and use of tranexamic acid treatments in prophylaxis and acute crisis, experience in Perú].","authors":"Oscar Calderón, Danny Muñoz, Margarita Olivares","doi":"10.29262/ram.v71i1.1319","DOIUrl":"10.29262/ram.v71i1.1319","url":null,"abstract":"<p><strong>Background: </strong>Hereditary Angioedema (HAE) is a rare disease characterized by episodes of swelling, HAE crisis could cause death by suffocation, and also affect the quality of life in these patients. There exists an important disparity of HAE specific treatments between countries, inclusive in the same region, currently in Perú we use moderate and high doses of Tranexamic Acid (TA) in prophylaxis therapy and in acute HAE crisis respectively.</p><p><strong>Objective: </strong>To report our experience with TA in three types of HAE patients and be a guide to other countries with this therapy, where HAE specific treatments are not registered.</p><p><strong>Case report: </strong><i><b>Patient 1:</b></i> Woman. 49 years old. HAE-1. Symptoms began at the age of 12. Her final diagnosis was at age 45. Usually presents an acute crisis every two months approximately, she receives 2 g IV of TA when lips, tongue, facial episodes is beginning, eventually she needed other 1 - 2 g IV (after 4 hours). She receives Long-Term Prophylaxis (LTP) with TA (500 - 750 mg)/12 h. <i><b>Patient 2:</b></i> Woman 47 years old, HAE nC1INH-FXII. Symptoms began at the age of 19, during her first pregnancy, her definitive diagnosis was at the age of 41 years. She maintains a prophylaxis treatment of TA (750 mg-1,5 g)/daily; upper airway attacks are treated immediately with TA doses (1 - 2 g) when the crisis is beginning. <i><b>Patient 3:</b></i> Woman 43 years old, HAE-nC1INH-U. Genetic study did not recognize SERPING1, PLG1, ANGPT1, KNG1, FXII, mutations. Symptoms began at age 4, and her final diagnosis was at age 36. When the attack is beginning, she immediately receives TA (500 - 750 mg) orally / 12 hours during 2 to 3 days with acceptable tolerance and control of the HAE episodes. While the patients receive TA prophylaxis treatment doses (500 - 750 mg) every 8 or 12 hours respectively, the HAE episodes are less symptomatic and resolve in a few days.</p><p><strong>Conclusions: </strong>We found this systematic review, used TA orally, on-demand and prophylaxis therapy, maximum cumulative dose 3 g/24 h<sup>1</sup>. In our HAE patients, we used TA up to 4 g (2 g - 2 g) intravenous for control of acute crisis in a interval of 4 hours, when decreases the reaction, the orally maintenance dose should be prescribed, 1 g/8 h with a progressive decrease of the dose in the next days. Tranexamic Acid treatment was useful in our different types of HAE patients. Most of our patients use high doses of TA to slow down and stop slowly the HAE crisis. TA is probably an option in countries where specific treatments are not registered, it could be administered orally and/or intravenous. High doses of TA were well tolerated and with acceptable response in HAE attacks.</p>","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"71 1","pages":"55"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140873478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical case of anaphylaxis due to eye drops]. [滴眼液引起过敏性休克的临床病例]。
Pub Date : 2024-02-01 DOI: 10.29262/ram.v71i1.1324
Iván Tinoco-Moran, Oscar Calderón-Liosa, Margarita Olivares-Gómez, Victor Farinango-Salazar, Iván Chérrez-Ojeda

Background: Anaphylaxis is a severe systemic allergic reaction that can be life-threatening, timely diagnosis and treatment is required in these patients, one of the most frequent triggers is pharmacological.

Objective: To report the case of a patient who presented anaphylaxis due to eye drops.

Case report: A 7-year-old male with a history of rhinitis and asthma with good control. It started with itchy eyes, ophthalmic drops were administered, composition: Polyethylene glycol 400, 0.4%, Propylene glycol 3 mg, polyquad 0.001%, presenting at 15 minutes an episode of anaphylaxis initially characterized by pruritus and intense conjunctival erythema, later nausea, vomiting, sweating, weakness, urticaria/facial angioedema and dyspnea were added, this episode was controlled opportunely with Levocetirizine 5 mg sublingual and Betametasona 4 mg intramuscular, progressively improving over the next 2 hours. The patient was evaluated by the Allergist, written recommendations were given to the mother in case this reaction occurred again, the use of the drops was prohibited, and the performance of skin test and a probable conjunctival provocation protocolized with the ophthalmic drops were pending. Accidentally 2 months later the patient was re-exposed with the same eye drops, presenting a similar reaction 15 minutes after the administration of the medication, they went to the emergency room where he received antihistamine and corticosteroid intravenous treatment, after this re-exposure is confirmed to the ophthalmic drops mentioned above as a trigger of anaphylaxis in this patient.

Conclusions: We present a case of conjunctival anaphylaxis after application of eye drops, confirmed by re-exposure to the drug. It is essential to give diagnoses, recommendations with treatments and avoidance of the probable triggering agent of the reaction. The administration of immediate medication when the allergic episode begins in these patients can be vital, even more so when they live far from a health center, as was the case in this patient.

背景:过敏性休克是一种严重的全身性过敏反应,可危及生命:过敏性休克是一种严重的全身性过敏反应,可危及生命,这些患者需要及时诊断和治疗,而最常见的诱发因素之一是药物:目的:报告一例因滴眼药水引起过敏性休克的患者:患者为一名 7 岁男性,有鼻炎和哮喘病史,病情控制良好。病例报告:一名 7 岁男性,有鼻炎和哮喘病史,病情控制良好:15 分钟后出现过敏性休克,最初表现为瘙痒和强烈的结膜红斑,随后又出现恶心、呕吐、出汗、虚弱、荨麻疹/面部血管性水肿和呼吸困难等症状,随后使用左西替利嗪 5 毫克舌下含服和倍他米松 4 毫克肌肉注射,病情在接下来的 2 小时内逐渐好转。过敏科医生对患者进行了评估,并向其母亲提出了书面建议,以防再次出现这种反应,同时禁止使用滴眼液,并等待进行皮试和可能的结膜刺激试验。2 个月后,患者再次意外接触了同样的滴眼液,在用药 15 分钟后出现了类似的反应,他们前往急诊室,接受了抗组胺药和皮质类固醇的静脉注射治疗:我们介绍了一例使用滴眼液后发生结膜过敏性休克的病例,再次接触药物后证实了这一点。诊断、建议治疗和避免使用可能诱发过敏反应的药物至关重要。当这些患者开始出现过敏反应时,立即给他们用药至关重要,如果他们住得离医疗中心很远,就更有必要了。
{"title":"[Clinical case of anaphylaxis due to eye drops].","authors":"Iván Tinoco-Moran, Oscar Calderón-Liosa, Margarita Olivares-Gómez, Victor Farinango-Salazar, Iván Chérrez-Ojeda","doi":"10.29262/ram.v71i1.1324","DOIUrl":"10.29262/ram.v71i1.1324","url":null,"abstract":"<p><strong>Background: </strong>Anaphylaxis is a severe systemic allergic reaction that can be life-threatening, timely diagnosis and treatment is required in these patients, one of the most frequent triggers is pharmacological.</p><p><strong>Objective: </strong>To report the case of a patient who presented anaphylaxis due to eye drops.</p><p><strong>Case report: </strong>A 7-year-old male with a history of rhinitis and asthma with good control. It started with itchy eyes, ophthalmic drops were administered, composition: Polyethylene glycol 400, 0.4%, Propylene glycol 3 mg, polyquad 0.001%, presenting at 15 minutes an episode of anaphylaxis initially characterized by pruritus and intense conjunctival erythema, later nausea, vomiting, sweating, weakness, urticaria/facial angioedema and dyspnea were added, this episode was controlled opportunely with Levocetirizine 5 mg sublingual and Betametasona 4 mg intramuscular, progressively improving over the next 2 hours. The patient was evaluated by the Allergist, written recommendations were given to the mother in case this reaction occurred again, the use of the drops was prohibited, and the performance of skin test and a probable conjunctival provocation protocolized with the ophthalmic drops were pending. Accidentally 2 months later the patient was re-exposed with the same eye drops, presenting a similar reaction 15 minutes after the administration of the medication, they went to the emergency room where he received antihistamine and corticosteroid intravenous treatment, after this re-exposure is confirmed to the ophthalmic drops mentioned above as a trigger of anaphylaxis in this patient.</p><p><strong>Conclusions: </strong>We present a case of conjunctival anaphylaxis after application of eye drops, confirmed by re-exposure to the drug. It is essential to give diagnoses, recommendations with treatments and avoidance of the probable triggering agent of the reaction. The administration of immediate medication when the allergic episode begins in these patients can be vital, even more so when they live far from a health center, as was the case in this patient.</p>","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"71 1","pages":"71"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140859491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Design and implementation of a transdisciplinary care model for patients with hereditary angioedema, in a Colombian health institution]. [哥伦比亚医疗机构为遗传性血管性水肿患者设计和实施跨学科护理模式]。
Pub Date : 2024-02-01 DOI: 10.29262/ram.v71i1.1378
Valentina Prada-Moreno, Juan David Wilches-Gutiérrez, Diana Roció Arias-Osorio

Objective: Describe the design and implementation of a transdisciplinary care model for patients with hereditary angioedema in Colombia.

Methods: Descriptive longitudinal observational study. 140 patients with hereditary angioedema were included in a transdisciplinary care model for one year. Seizure rates, hospitalizations, emergency room visits, quality of life, and pharmacological adherence were measured.

Results: The model was associated with reductions of 76% in seizures, 66% in hospitalizations, and 87% in emergency room visits. Pharmacological adherence increased 19% and was complete after four months. The quality of life increased significantly.

Conclusions: Hereditary angioedema is an orphan disease that requires a comprehensive approach for effective care.

目的:描述哥伦比亚为遗传性血管性水肿患者设计和实施的跨学科护理模式:描述哥伦比亚为遗传性血管性水肿患者设计和实施的跨学科护理模式:描述性纵向观察研究。140 名遗传性血管性水肿患者被纳入跨学科护理模式,为期一年。对发作率、住院率、急诊就诊率、生活质量和药物依从性进行了测量:结果:采用该模式后,癫痫发作率降低了 76%,住院率降低了 66%,急诊就诊率降低了 87%。服药依从性提高了 19%,并在四个月后达到完全依从。生活质量明显提高:遗传性血管性水肿是一种孤儿病,需要采用综合方法进行有效治疗。
{"title":"[Design and implementation of a transdisciplinary care model for patients with hereditary angioedema, in a Colombian health institution].","authors":"Valentina Prada-Moreno, Juan David Wilches-Gutiérrez, Diana Roció Arias-Osorio","doi":"10.29262/ram.v71i1.1378","DOIUrl":"10.29262/ram.v71i1.1378","url":null,"abstract":"<p><strong>Objective: </strong>Describe the design and implementation of a transdisciplinary care model for patients with hereditary angioedema in Colombia.</p><p><strong>Methods: </strong>Descriptive longitudinal observational study. 140 patients with hereditary angioedema were included in a transdisciplinary care model for one year. Seizure rates, hospitalizations, emergency room visits, quality of life, and pharmacological adherence were measured.</p><p><strong>Results: </strong>The model was associated with reductions of 76% in seizures, 66% in hospitalizations, and 87% in emergency room visits. Pharmacological adherence increased 19% and was complete after four months. The quality of life increased significantly.</p><p><strong>Conclusions: </strong>Hereditary angioedema is an orphan disease that requires a comprehensive approach for effective care.</p>","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"71 1","pages":"80"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140874296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Molecular mimicry between human thyroid peroxidase, thyroglobulin, cosinophil peroxidase, IL-24 and microorganisms antigens]. [人甲状腺过氧化物酶、甲状腺球蛋白、嗜酸性粒细胞过氧化物酶、IL-24 和微生物抗原之间的分子模拟]。
Pub Date : 2024-02-01 DOI: 10.29262/ram.v71i1.1376
Andrés Sánchez, Valentina García, Yuliana Marcela Emiliani-Navarro, Jorge Sánchez, Juan Camilo Ramos-Gomez, Sonia Karina González-Rangel, Marlon Munera-Gomez

Objective: Identify molecular mimicry between TPO, eosinophil peroxidase (EPX), thyroglobulin and IL24 and microorganism antigens.

Methods: Through in silico analysis, we performed local alignments between human and microorganism antigens with PSI-BLAST. Proteins that did not present a 3D structure were modeled by homology through the Swiss Modeller server and epitope prediction was performed through Ellipro. Epitopes were located in the 3D models using PYMOL software.

Results: A total of 38 microorganism antigens (parasites, bacteria) had identities between 30% and 45%, being the highest with Anisakis simplex. The alignment between 2 candidate proteins from A. simplex and EPX presented significant values, with identities of 43 and 44%. In bacteria, Campylobacter jejuni presented the highest identity with thyroglobulin (35%). 220 linear and conformational epitopes of microorganism antigens were predicted. Peroxidasin-like proteins from Toxocara canis and Trichinella pseudospiralis presented 10 epitopes similar to TPO and EPX, as possible molecules triggering cross-reactivity. No virus presented identity with the human proteins studied.

Conclusion: TPO and EPX antigens shared potential cross-reactive epitopes with bacterial and nematode proteins, suggesting that molecular mimicry could be a mechanism that explains the relationship between infections and urticaria/hypothyroidism. In vitro work is needed to demonstrate the results obtained in the in silico analysis.

目的:确定TPO、嗜酸性粒细胞过氧化物酶(EPX)、甲状腺球蛋白和IL24与微生物抗原之间的分子模拟:确定TPO、嗜酸性粒细胞过氧化物酶(EPX)、甲状腺球蛋白和IL24与微生物抗原之间的分子拟态:我们利用 PSI-BLAST 进行了人类抗原与微生物抗原之间的局部比对。对于没有三维结构的蛋白质,我们通过 Swiss Modeller 服务器进行了同源建模,并通过 Ellipro 进行了表位预测。使用PYMOL软件在三维模型中定位表位:共有 38 种微生物抗原(寄生虫、细菌)的同源性在 30% 至 45% 之间,其中与单纯疟原虫的同源性最高。单纯疟原虫的两种候选蛋白质与 EPX 的比对结果显示出显著的相同值,分别为 43% 和 44%。在细菌中,空肠弯曲杆菌与甲状腺球蛋白的同一性最高(35%)。预测了 220 个微生物抗原的线性表位和构象表位。来自犬弓形虫和假螺旋体毛癣菌的过氧化物酶样蛋白呈现出 10 个与 TPO 和 EPX 相似的表位,可能是引发交叉反应的分子。没有一种病毒与所研究的人类蛋白质有相同之处:结论:TPO和EPX抗原与细菌和线虫蛋白具有潜在的交叉反应表位,这表明分子模仿可能是解释感染与荨麻疹/甲状腺功能减退症之间关系的一种机制。需要开展体外工作来证明在硅学分析中获得的结果。
{"title":"[Molecular mimicry between human thyroid peroxidase, thyroglobulin, cosinophil peroxidase, IL-24 and microorganisms antigens].","authors":"Andrés Sánchez, Valentina García, Yuliana Marcela Emiliani-Navarro, Jorge Sánchez, Juan Camilo Ramos-Gomez, Sonia Karina González-Rangel, Marlon Munera-Gomez","doi":"10.29262/ram.v71i1.1376","DOIUrl":"10.29262/ram.v71i1.1376","url":null,"abstract":"<p><strong>Objective: </strong>Identify molecular mimicry between TPO, eosinophil peroxidase (EPX), thyroglobulin and IL24 and microorganism antigens.</p><p><strong>Methods: </strong>Through in silico analysis, we performed local alignments between human and microorganism antigens with PSI-BLAST. Proteins that did not present a 3D structure were modeled by homology through the Swiss Modeller server and epitope prediction was performed through Ellipro. Epitopes were located in the 3D models using PYMOL software.</p><p><strong>Results: </strong>A total of 38 microorganism antigens (parasites, bacteria) had identities between 30% and 45%, being the highest with Anisakis simplex. The alignment between 2 candidate proteins from A. simplex and EPX presented significant values, with identities of 43 and 44%. In bacteria, Campylobacter jejuni presented the highest identity with thyroglobulin (35%). 220 linear and conformational epitopes of microorganism antigens were predicted. Peroxidasin-like proteins from Toxocara canis and Trichinella pseudospiralis presented 10 epitopes similar to TPO and EPX, as possible molecules triggering cross-reactivity. No virus presented identity with the human proteins studied.</p><p><strong>Conclusion: </strong>TPO and EPX antigens shared potential cross-reactive epitopes with bacterial and nematode proteins, suggesting that molecular mimicry could be a mechanism that explains the relationship between infections and urticaria/hypothyroidism. In vitro work is needed to demonstrate the results obtained in the in silico analysis.</p>","PeriodicalId":101421,"journal":{"name":"Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)","volume":"71 1","pages":"57"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140873739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1